NORTHPOINTE CAPITAL LLC - PERNIX THERAPEUTICS HLDGS IN ownership

PERNIX THERAPEUTICS HLDGS IN's ticker is PTX and the CUSIP is 71426V108. A total of 99 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q4 2014. The put-call ratio across all filers is 3.13 and the average weighting 0.4%.

Quarter-by-quarter ownership
NORTHPOINTE CAPITAL LLC ownership history of PERNIX THERAPEUTICS HLDGS IN
ValueSharesWeighting
Q1 2015$1,807,000
+89.2%
169,066
+66.3%
0.20%
+70.4%
Q4 2014$955,000
-29.0%
101,686
-42.0%
0.12%
-19.6%
Q3 2014$1,346,000
-63.1%
175,261
-56.8%
0.14%
-59.4%
Q2 2014$3,646,000
+53.5%
405,980
-8.6%
0.35%
+46.1%
Q1 2014$2,375,000443,9700.24%
Other shareholders
PERNIX THERAPEUTICS HLDGS IN shareholders Q4 2014
NameSharesValueWeighting ↓
Sageview Capital 2,223,339$5,603,0001.59%
Orbimed Advisors 2,320,800$5,848,0000.09%
F&C Asset Management plc 1,854,808$4,665,0000.06%
SPHERA FUNDS MANAGEMENT LTD. 56,500$142,0000.04%
Yakira Capital Management, Inc. 11,957$30,0000.03%
Spectrum Management Group, LLC 10,000$25,0000.02%
Weiss Multi-Strategy Advisers LLC 41,152$104,0000.00%
WOLVERINE ASSET MANAGEMENT LLC 30,000$75,0000.00%
PUTNAM INVESTMENTS LLC 129,762$327,0000.00%
Partnervest Advisory Services LLC 220$1,0000.00%
View complete list of PERNIX THERAPEUTICS HLDGS IN shareholders